Top Qs
Timeline
Chat
Perspective
Motexafin lutetium
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Motexafin lutetium is a texaphyrin, marketed as Antrin by Pharmacyclics Inc.
It is a photosensitiser for use in photodynamic therapy to treat skin conditions and superficial cancers.
It has also been tested for use in photoangioplasty (photodynamic treatment of diseased arteries).[1]
It is photoactivated by 732 nm light which allows greater depth of penetration.[2]
Remove ads
Clinical trials
Phase II clinical trials were in progress in 1999.[3]
A phase I trial for prostate cancer reported in 2009.[4]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads